| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/02/2003 | US20030003581 Method for targeting transcriptionally active loci |
| 01/02/2003 | US20030003574 Multipotent stem cells from peripheral tissues and uses thereof |
| 01/02/2003 | US20030003567 Packaging cells |
| 01/02/2003 | US20030003566 Cell line preparing and producing ovine adenovirus vectors |
| 01/02/2003 | US20030003565 Functional lentiviral vector from an MLV-based backbone |
| 01/02/2003 | US20030003559 Nucleotide sequences coding polypeptide for use in the treatment of diabetes, kidney, and liver disorders |
| 01/02/2003 | US20030003558 Nucleotide sequences coding enzymatic polypeptide for use in the generation of medicine, animal nutrients and foods |
| 01/02/2003 | US20030003557 Nucleotide sequences coding polypeptide for use in the generation of disease and herbicide resistant plants |
| 01/02/2003 | US20030003556 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same |
| 01/02/2003 | US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 01/02/2003 | US20030003551 Method for producing dihydroxyacetone-3-phosphate |
| 01/02/2003 | US20030003550 Microorganism for use in the generation of glutamine; for use in maintaining liver health |
| 01/02/2003 | US20030003547 Controlling homologous recombination; obtain nucleotide sequence, incubate with oligonucleotide, monitor adjustment in gene and phenotypic expression |
| 01/02/2003 | US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects |
| 01/02/2003 | US20030003544 44576, a novel G-protein coupled receptor and uses therefor |
| 01/02/2003 | US20030003542 ACPL polypeptides |
| 01/02/2003 | US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders |
| 01/02/2003 | US20030003539 Nucleotide sequences coding polypeptide for use in the treatment of blood, apoptosis, inflamation and brain disorders |
| 01/02/2003 | US20030003535 Single chain class I major histo-compatibility complexes |
| 01/02/2003 | US20030003534 Isolation of preferential proteins from cells; obtain cells, incubate with reducing agents and detergent, recover proteins |
| 01/02/2003 | US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides |
| 01/02/2003 | US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2003 | US20030003529 Vitro modification of glycosylation patterns of recombinant glycopeptides |
| 01/02/2003 | US20030003528 Generation of carotenoid compound; obtain gnetically engineeered cell, incubate with carbon substrate, recover carotene compound |
| 01/02/2003 | US20030003525 Novel promoter of gene expression |
| 01/02/2003 | US20030003519 Compositions and methods for the discovery and selection of biological information |
| 01/02/2003 | US20030003516 Therapeutic and diagnostic uses of antibody specificity profiles |
| 01/02/2003 | US20030003511 Closure of bacterial ghost |
| 01/02/2003 | US20030003498 Analyzing preferential nucleotide sequences; obtain sample, incubate with primer, amplify, apply an electric field, detect and recover nucleotide sequences products |
| 01/02/2003 | US20030003496 Novel compositions and methods for array-based nucleic acid hybridization |
| 01/02/2003 | US20030003490 Mapping preferential nucleic acid position in biopolymer; obtain nucleotide sequence sample, incubate with probe, amplify, determine position of preferential nucleotide sequences |
| 01/02/2003 | US20030003489 Nucleotide sequences coding peptides for use in the treatment of tumors |
| 01/02/2003 | US20030003486 Oligonucleotide for use as signaling tool in genetic analysis |
| 01/02/2003 | US20030003483 Amplifiable probe |
| 01/02/2003 | US20030003478 Identifying and characterizing genes |
| 01/02/2003 | US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders |
| 01/02/2003 | US20030003472 Detection of genetic aberration in sample; obtain nucleotide sequences, incubate with oligonucleotides, detect aberration in hybridization, presence of aberration indicates variablity in nucleotide sequences |
| 01/02/2003 | US20030003470 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 01/02/2003 | US20030003469 Ribozyme treatment of diseases or conditions related to levels of NF-kappaB |
| 01/02/2003 | US20030003468 Markers for disease susceptibility and targets for therapy |
| 01/02/2003 | US20030003466 Artificial mammalian chromosome |
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003461 Truncation selex method |
| 01/02/2003 | US20030003454 Diagnosing cancer in humans; obtain tissue sample, monitor expression of nucleotide sequences maintanance enzymes, amplified concentration of enzyme indicates cancer |
| 01/02/2003 | US20030003453 DNA molecule encoding a variant paraoxonase and uses thereof |
| 01/02/2003 | US20030003452 Polymerase for use in the treatment of infections, respiratory, blood, alzheimer's, muscular and cancerous disorders |
| 01/02/2003 | US20030003449 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003444 R9Detection of preferential polypeptide in sample; obtain sample of polypeptide, incubate with bacteriophage, monitor adjustment in activity, adjustment in activity |
| 01/02/2003 | US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 01/02/2003 | US20030003442 Retrovirus from the HIV group and its use |
| 01/02/2003 | US20030003439 Monitoring the activity of preferential proteins in sample; obtain polypeptide sample, incubate with testing agent and cells, monitor adjustment in ccll activity, adjustment in cell activity indicates protein interacion |
| 01/02/2003 | US20030003435 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 01/02/2003 | US20030003143 Lipidic microparticles linked to multiple proteins |
| 01/02/2003 | US20030003121 Antiallergic agent |
| 01/02/2003 | US20030003112 Avipox virus containing foreign DNA from porcine reproductive and respiratory syndrome virus; immunological compositions containing the recombinant poxvirus for inducing an immunological response in a host animal |
| 01/02/2003 | US20030003103 Sequences for targeting metastatic cells |
| 01/02/2003 | US20030003101 Treatment and diagnosis of prostate cancer |
| 01/02/2003 | US20030003100 Gene therapy strategy, comprising an antibody-nucleic acid-cationic macromolecule complex that enhances nucleic acid delivery to mammalian cells |
| 01/02/2003 | US20030003097 Recombinant antibodies coexpressed with GnTIII |
| 01/02/2003 | US20030003096 Only specifically binds activated factor VII, and not factor VII, and does not bind to an activated factor VII which is complexed with antithrombin III |
| 01/02/2003 | US20030003085 Drug delivery of a muscle protein by administering purified donor muscle side population cells; gene therapy, in the treatment muscle diseases muscular dystrophies, genetic diseases, treating cancer, and bone marrow transplant |
| 01/02/2003 | US20030003080 Reovirus for the treatment of cellular proliferative disorders |
| 01/02/2003 | US20030003079 Recombinant pox virus for immunization against tumor-associated antigens |
| 01/02/2003 | US20030003077 A genetic engineered adenoviral vector contains an adenoviral genome from which the open reading frames E1 and/or E3 were deleted and a therapeutic gene or a DNA sequence that encodes for therapeutic proteins useful in fibrosis treatment |
| 01/02/2003 | US20030003076 Adenovirus E1B-55K single amino acid mutants and methods of use |
| 01/02/2003 | US20030003050 Detecting a difference in an untranslated region of mRNA for a gene in which diversity in untranslated region of mRNA affects sensitivity to a drug, and evaluating sensitivity to a drug based on the detected difference |
| 01/02/2003 | EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker |
| 01/02/2003 | EP1271149A2 Structure with immobilized biological material and method for manufacturing the same |
| 01/02/2003 | EP1271146A1 Method and composition of cellular reprogramming |
| 01/02/2003 | EP1270746A1 Methods for the identification of ligand and target biomolecules |
| 01/02/2003 | EP1270745A2 Thymosin B15 as a marker in diagnosis and prognosis of cancer |
| 01/02/2003 | EP1270744A1 Reporter gene construct for the detection of HIV rev and HIV tat |
| 01/02/2003 | EP1270742A1 Method of detecting risk factor for the onset of arteriosclerosis |
| 01/02/2003 | EP1270741A1 Nucleotide sequences involved in plant disease resistance |
| 01/02/2003 | EP1270740A1 Biochip and its use for determining inflammation |
| 01/02/2003 | EP1270733A1 Method for introducing a nucleic acid into a eukaryotic cell |
| 01/02/2003 | EP1270732A1 Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 01/02/2003 | EP1270731A1 Method for increasing the content of carotinoids in transgenic plants |
| 01/02/2003 | EP1270730A1 Process for producing polypeptide having disulfide bond |
| 01/02/2003 | EP1270729A1 Dna molecule coding for a polygalacturonase of strawberry and the uses thereof |
| 01/02/2003 | EP1270728A1 Process for producing avermectin derivative |
| 01/02/2003 | EP1270727A1 Salutaridinol 7-O-acetyltransferase and derivatives thereof |
| 01/02/2003 | EP1270726A1 69624, a human transporter family member and uses therefor |
| 01/02/2003 | EP1270725A1 Anticalines |
| 01/02/2003 | EP1270724A2 Guanosine triphosphate-binding protein coupled receptors |
| 01/02/2003 | EP1270723A1 Anticomplement polyptide from salivary glands of the tick Ixodes ricinus |
| 01/02/2003 | EP1270721A1 Recombinant DNA sequences encoding feedback inhibition released enzymes, plasmids comprising the recombinant DNA sequences, transformed microorganisms useful in the production of aromatic amino acids, and a process for preparing aromatic amino acids by fermentation |
| 01/02/2003 | EP1270720A2 Activated rec-D-Hydantoinases |
| 01/02/2003 | EP1270595A1 Gene recombinant antibody and its fragment |
| 01/02/2003 | EP1270594A1 Antibodies to peptide from a soluble fragment of acetylcholinesterase |
| 01/02/2003 | EP1270593A2 HSCA-3 antigen and monoclonal antibody which recognizes the antigen |
| 01/02/2003 | EP1270591A1 Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells |
| 01/02/2003 | EP1270590A1 Human CD24-like protein and nucleic acids encoding it |
| 01/02/2003 | EP1270589A1 Novel leukotriene b4 receptor |
| 01/02/2003 | EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/02/2003 | EP1270587A1 Transporter proteins for oxoderivatives of nitrogen-containing heterocyclic compounds and coding nucleic acids |
| 01/02/2003 | EP1270586A2 Composition for the cell-specific transfer of active substances |
| 01/02/2003 | EP1270044A2 Wound healing biomarkers |
| 01/02/2003 | EP1270016A1 Aids virus vaccine with the use of sendai virus vector |